Medpace is ready to help you with your next clinical trial project. Find out more about how we can help.

GO NOW

Effective Date: 7-FEB-2012

The Foreign Corrupt Practices Act ("FCPA") is a United States federal law that applies to Medpace and its international subsidiaries. The UK Anti-Bribery Act also applies to Medpace and its subsidiaries. All Medpace companies around the world potentially fall within the scope of these laws.

Anti-Bribery and Corruption Policy

• The FCPA and the UK Anti-Bribery Act prohibit companies or individuals from directly or indirectly making payments or offering anything of value to government officials or private individuals for the purpose of influencing any official act or decision, or encouraging or discouraging any action in violation or any legal duty, to secure an improper business advantage.
• Medpace is committed to full compliance with the FCPA and the UK Anti-Bribery Act. Medpace strictly prohibits make any payments or providing gifts or anything of value, or offering payments, gifts or anything of value to a government official or private individual to influence an official act or decision or to induce the person to do or not do anything in violation of the person's legal duty, in order to gain a business advantage. This includes any payments, gifts or favors, using Medpace funds or personal funds, by any Medpace employee, or by any third party on behalf of Medpace or a Medpace employee.
• Government official includes anyone who is an officer, employee or representative of a government of any country, or a state-owned entity including, for example, government-owned or controlled hospitals or physicians, or members of agencies or committees performing government functions such as granting, withholding or withdrawing regulatory approvals, licenses and permits.
• In order to ensure compliance with the law, it is essential that Medpace financial records accurately and fairly reflect all corporate transactions, no matter how small. Recording any payments, gifts or other expenditures in any way that would conceal their true nature, the recipient, or the amount is also a violation of this policy. No undisclosed or unrecorded funds or assets of Medpace are to be established for any purpose.

Enforcement of this Policy

• The Medpace Corporate Compliance Officer, acting on behalf of and under the authority of the company's Board of Directors, is responsible for the enforcement of this policy. The Corporate Compliance Officer works with management to develop, implement, maintain and monitor appropriate policies and procedures which support compliance, inform Medpace employees and contractors of their specific responsibilities under this policy, monitor for compliance, and address any non-compliance. The Corporate Compliance Officer periodically reports on these efforts to the Board of Directors.
• Violation of the law on which this policy is based can subject Medpace and its Board of Directors, management and employees to prosecution, criminal fines and imprisonment. All employees are accountable for their actions and are required to report any actual or suspected violations of this policy to the Corporate Compliance Officer. Managers are ultimately responsible for ensuring the employees they supervise are knowledgeable about and in compliance with this policy, the FCPA and the UK Anti-Bribery Act. Any employee who violates this policy, or who is aware of by fails to report conduct that violates this policy, is subject to disciplinary action including termination, and legal action.